Logotipo do repositório
 

Publicação:
Differential antagonism by conotoxin p-TIA of contractions mediated by distinct alpha(1)-adrenoceptor subtypes in rat vas deferens, spleen and aorta

dc.contributor.authorLima, V
dc.contributor.authorMueller, A.
dc.contributor.authorKamikihara, S. Y.
dc.contributor.authorRaymundi, V
dc.contributor.authorAlewood, D.
dc.contributor.authorLewis, R. J.
dc.contributor.authorChen, Z. J.
dc.contributor.authorMinneman, K. P.
dc.contributor.authorPupo, A. S.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionXenome Ltd
dc.contributor.institutionEmory Univ
dc.date.accessioned2014-05-20T15:26:21Z
dc.date.available2014-05-20T15:26:21Z
dc.date.issued2005-01-31
dc.description.abstractThe ability of the conotoxin p-TIA, a 19-amino acid peptide isolated from the marine snail Conus tulipa, to antagonize contractions induced by noradrenaline through activation of alpha(1A)-adrenoceptors in rat vas deferens, alpha(1B)-adrenoceptors in rat spleen and alpha(ID)-adrenoceptors in rat aorta, and to inhibit the binding of [I-125]HEAT (2-[[beta-(4-hydroxyphenyl)ethyl]aminomethyl]-1-tetralone) to membranes of human embryonic kidney (HEK) 293 cells expressing each of the recombinant rat alpha(1)-adrenoceptors was investigated. p-TIA (100 nM to 1 muM) antagonized the contractions of vas deferens and aorta in response to noradrenaline without affecting maximal effects and with similar potencies (pA(2)similar to7.2, n=4). This suggests that p-TIA is a competitive antagonist of alpha(1A)- and alpha(1D)-adrenoceptors with no selectivity between these subtypes. Incubation of p-TIA (30 to 300 nM) with rat spleen caused a significant reduction of the maximal response to noradrenaline, suggesting that p-TIA is a non-competitive antagonist at alpha(1B)-adrenoceptors. After receptor inactivation with phenoxybenzamine, the potency of p-TIA in inhibiting contractions was examined with similar occupancies (similar to25%) at each subtype. Its potency (pIC(50)) was 12 times higher in spleen (8.3 +/- 0.1, n=4) than in vas deferens (7.2 +/- 0.1, n=4) or aorta (7.2 0.1, n=4). In radioligand binding assays, p-TIA decreased the number of binding sites (B,,,,,,) in membranes from HEK293 cells expressing the rat alpha(1B)-adrenoceptors without affecting affinity (K-D), In contrast, in HEK293 cells expressing rat alpha(1A)- or alpha(1D)-adrenoceptors, p-TTA decreased the KD without affecting the B-max. It is concluded that p-TIA will be useful for distinguishing the role of particular alpha(1)-adrenoceptor subtypes in native tissues. (C) 2004 Elsevier B.V. All rights reserved.en
dc.description.affiliationUniv Estadual Paulista Julio Mesquita Filho, Dept Pharmacol, Inst Biociencias, BR-18618000 Botucatu, SP, Brazil
dc.description.affiliationXenome Ltd, Indooroopilly, Qld 4068, Australia
dc.description.affiliationEmory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
dc.description.affiliationUnespUniv Estadual Paulista Julio Mesquita Filho, Dept Pharmacol, Inst Biociencias, BR-18618000 Botucatu, SP, Brazil
dc.format.extent183-192
dc.identifierhttp://dx.doi.org/10.1016/j.ejphar.2004.12.011
dc.identifier.citationEuropean Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 508, n. 1-3, p. 183-192, 2005.
dc.identifier.doi10.1016/j.ejphar.2004.12.011
dc.identifier.issn0014-2999
dc.identifier.lattes2224433126054725
dc.identifier.urihttp://hdl.handle.net/11449/36532
dc.identifier.wosWOS:000226894000023
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofEuropean Journal of Pharmacology
dc.relation.ispartofjcr3.040
dc.relation.ispartofsjr1,057
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectalpha(1)-adrenoceptorpt
dc.subjectconotoxin p-TIApt
dc.subjectvas deferenspt
dc.subjectspleenpt
dc.subjectaortapt
dc.titleDifferential antagonism by conotoxin p-TIA of contractions mediated by distinct alpha(1)-adrenoceptor subtypes in rat vas deferens, spleen and aortaen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
unesp.author.lattes2224433126054725[9]
unesp.author.orcid0000-0003-3470-923X[6]
unesp.author.orcid0000-0001-6627-3448[9]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatupt
unesp.departmentFarmacologia - IBBpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: